Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search
Fullscreen

For citations:


Parfenov V.A., Bogdanov E.I., Laskov V.B., Makarov N.S., Pisova N.V., Salina E.A., Chefranova Z.Yu., Chichanovskaya L.V. Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute non-specific lower back pain. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(6):14-22. (In Russ.)

Views: 156


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)